UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549


                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15 (d) of
                       the Securities Exchange Act of 1934


                         Date of Report: August 13, 2003
                        (Date of earliest event reported)


                                VASOMEDICAL, INC.
             (Exact name of registrant as Specified in its Charter)


        Delaware                       0-18105               11-2871434
(State or other jurisdiction of       Commission          (I.R.S. Employer
 incorporation or organization)       File Number)       Identification Number)

180 Linden Avenue, Westbury, New York                      11590
(Address of Principal Executive Offices)                 (Zip Code)

Registrant's Telephone Number, Including Area Code    (516) 997-4600


         (Former name or former address, if changed since last report.)



Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.

         (c)  Exhibits

         99   Press release dated August 13, 2003 issued by Vasomedical, Inc.
               ("Registrant").

Item 9.  Regulation FD Disclosure

     The following  information is furnished  pursuant to Item 9, "Regulation FD
Disclosure" and Item 12, "Results of Operations and Financial Condition."

     On August 13, 2003,  the Registrant  issued a press release  announcing the
Registrant's  financial  results for its fourth fiscal  quarter and for the year
ended May 31, 2003. A copy of the Registrant's  press release is attached hereto
as Exhibit 99.

     The  information in this Form 8-K is being  furnished under Item 9 and Item
12 and shall not be deemed to be "filed"  for the  purposes of Section 18 of the
Securities and Exchange Act of 1934 (the "Exchange  Act"), or otherwise  subject
to the  liabilities  of such  section,  nor  shall  such  information  be deemed
incorporated by reference in any filing under the Securities Act of 1933, or the
Exchange Act,  except as shall be expressly  set forth by specific  reference in
such filing.


                                    SIGNATURE
                                    ---------

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                        VASOMEDICAL, INC.


                                        By:  /s/ Joseph A. Giacalone
                                             --------------------------
                                             Joseph A. Giacalone
                                             Chief Financial Officer
Dated:   August 13, 2003